ReviewFrontiers in immunology2025

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review.

Xiao-Yu Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.